Document Detail


The mifepristone-misoprostol regimen for early medical abortion.
MedLine Citation:
PMID:  12112968     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The combination of mifepristone, an antiprogesterone known in the United States as Mifeprex (Danco Laboratories, New York, NY), and misoprostol, a prostaglandin analogue marketed in the United States under the brand name Cytotec (Pharmacia [formerly Searle], Peapack, NJ), provides a nonsurgical abortion in the early stages of a pregnancy. Mifepristone blocks the action of progesterone, a hormone necessary to sustain a pregnancy, whereas misoprostol causes contractions that expel the embryo and other pregnancy tissue. Since September 2000, mifepristone has been approved by the United States Food and Drug Administration for induced abortions of gestations of 49 days or less since the last menstrual period, but is not yet approved for any other uses. Misoprostol has long been approved to prevent and treat stomach ulcers.
Authors:
C Ellertson; S N Waldman
Related Documents :
8546658 - Blood loss in termination of early pregnancy with mifepristone and gemeprost.
18165398 - Ultrasonographic endometrial thickness after medical and surgical management of early p...
2868938 - Prostaglandins in the fetal circulation following maternal ingestion of a prostaglandin...
1245238 - "second generation" prostaglandins: midtrimester pregnancy termination by intramuscular...
22714068 - Factors contributing to intra-uterine fetal death.
8706948 - Training in the management of critical problems: teacher's view.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current women's health reports     Volume:  1     ISSN:  1534-5874     ISO Abbreviation:  Curr Womens Health Rep     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2002-07-12     Completed Date:  2002-07-31     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  101120027     Medline TA:  Curr Womens Health Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  184-90     Citation Subset:  IM    
Affiliation:
cellertson@popcouncil.org.mx
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents / administration & dosage*
Abortion, Induced / methods*
Administration, Intravaginal
Administration, Oral
Drug Therapy, Combination
Female
Humans
Mifepristone / administration & dosage*
Misoprostol / administration & dosage*
Patient Satisfaction
Pregnancy
Pregnancy Trimester, First
Self Administration
Chemical
Reg. No./Substance:
0/Abortifacient Agents; 59122-46-2/Misoprostol; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Violence in the lives of young women: clinical care and management.
Next Document:  Release of progestin-only emergency contraception.